Brief: Design Therapeutics Q1 Basic EPS USD -0.29
28/04/2026 21:01
Apr 28 (Reuters) - Design Therapeutics Q1 net income USD -17.636 million vs. IBES estimate USD -19.6 million. Q1 operating income USD -19.706 million Q1 operating expenses USD 19.706 million
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1